Vivid iq vs Tempus ECG-AF
AI Verdict
Choose Vivid iq if…
Choose Vivid iq if your clinical setting requires highly portable, real-time, and comprehensive cardiovascular imaging capabilities at the point of care. This system is ideal for emergency medicine, mobile clinics, or situations where immediate, high-resolution 2D and 4D ultrasound diagnostics are crucial for guiding treatment decisions across multiple specialties.
View Vivid iq →Choose Tempus ECG-AF if…
Choose Tempus ECG-AF if your objective is to proactively identify older patients (65+) at elevated risk of developing new-onset atrial fibrillation within the next year, leveraging existing 12-lead ECG data. This software solution is best suited for integrating into cardiology and internal medicine workflows to enhance population health management and enable earlier preventative interventions for at-risk individuals.
View Tempus ECG-AF →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Vivid iq | Tempus ECG-AF |
|---|---|---|
| Pricing | Starts at $7,650 (refurbished) to $38,388 (new). leasing options start at $547.82/month or $999/month. | Contact vendor |
| Deployment | On-premise | Software solution, integrated into healthcare facility systems with advanced cardiology algorithms. |
| BAA Available | Yes AI-estimated | Yes AI-estimated |
| FDA Status | Cleared AI-estimated | Yes AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Vivid iqVivid iq features a dedicated 15.6-inch multi-touch screen with trackpad gestures and AI-powered tools that significantly reduce manual steps and keystrokes, enhancing workflow efficiency and user comfort. In contrast, Tempus ECG-AF operates without a dedicated user interface, integrating into existing medical systems, which means direct user interaction with the algorithm is not possible.
Clinical Value
Tempus ECG-AFTempus ECG-AF offers a unique and impactful clinical value by providing an FDA-cleared AI-based algorithm to predict the risk of atrial fibrillation within 12 months from standard ECGs, supporting earlier identification and follow-up for a critical condition. This predictive capability, trained on a massive dataset of over 1.5 million ECGs, represents a significant step towards preventative medicine. While Vivid iq provides high-resolution diagnostic imaging, Tempus ECG-AF's specific, proactive risk assessment for AF stands out.
Pricing & Value
Tempus ECG-AFTempus ECG-AF provides a clear financial pathway for adoption with established CMS reimbursement codes (CPT 0764T and CPT 0765T) and a Medicare rate of $128.90, effective January 1, 2025. This transparency and recognized reimbursement significantly enhance its value proposition for healthcare providers. Vivid iq, while having observed sale prices, lacks explicit information on specific reimbursement pathways, making its overall financial value less clear.
Enterprise Readiness
Tempus ECG-AFBoth tools are FDA-cleared, HIPAA compliant, and offer BAAs, indicating foundational enterprise readiness. However, Tempus ECG-AF is a software solution designed for integration into existing healthcare facility systems via standard communication protocols like APIs and file exchanges, which allows for more scalable and less physically intrusive deployment across a large enterprise. Tempus also offers a broader suite of AI applications and EHR integration capabilities, suggesting a more comprehensive approach to digital health strategy.
Innovation
Tempus ECG-AFTempus ECG-AF demonstrates greater innovation by being the first FDA-cleared AI-based algorithm for predicting the risk of atrial fibrillation/flutter within 12 months from standard 12-lead ECGs. This represents a novel application of AI for proactive risk prediction in cardiovascular health. While Vivid iq innovates in making advanced ultrasound technology highly portable and AI-enhanced, Tempus ECG-AF's predictive diagnostic capability is a more groundbreaking application of AI in preventative medicine.
Support & Docs
Vivid iqGE HealthCare, the company behind Vivid iq, has a well-established support infrastructure with a dedicated online documentation library, clinical education resources, and contact information. While Tempus AI offers general customer support for its products, specific details regarding comprehensive documentation and dedicated support channels for the ECG-AF algorithm are less explicit in the provided information.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Vivid iq | Tempus ECG-AF |
|---|---|---|
| Name | Vivid iq | Tempus ECG-AF |
| Company | GE Medical Systems Ultrasound and Primary Care Diagnostics | Tempus AI, Inc. |
| Description | GE HealthCare's Vivid iq is an AI-powered, ultra-portable cardiovascular ultrasound system offering high-resolution 2D and 4D imaging with advanced quantification tools for efficient and accurate diagnostics across various medical specialties. | Tempus ECG-AF is an FDA-cleared AI-based algorithm that analyzes 12-lead ECG recordings to identify patients aged 65 or older at increased risk of developing atrial fibrillation/flutter (AF) within the next 12 months, supporting earlier identification and follow-up. |
| Categories | Cardiology AI, Radiology & Imaging AI | Cardiology AI |
| Specialties | Cardiology, Emergency Medicine, Radiology | Cardiology, Geriatrics, Internal Medicine |
Videos
Demos, reviews, and walkthroughs featuring Vivid iq and Tempus ECG-AF.